“It’s already three doses and a booster, so let’s just call it four doses,” he says. “The more doses, the more challenges you’re going to have with uptake and adherence. And if there are annual doses, and if it’s expensive and inconvenient, I think that’s going to limit the uptake.”
Read full article on The Growth Op
